INTRODUCTION
============

Upper gastrointestinal (UGI) endoscopy enables physicians to estimate the secreting ability of gastric mucosa and gastric cancer risk based on the findings of the background gastric mucosa ([Fig. 1](#f1-kjim-2016-166){ref-type="fig"}). To measure the secreting ability of gastric mucosal cells, noninvasive serologic tests are preferred over invasive tube tests \[[@b1-kjim-2016-166]\]. Noninvasive tests consist of the serum pepsinogen (PG) assay, calcium carbonate breath test, and hydrogen breath test, while invasive tests consist of aspiration tests (pentagastrin and tetragastrin tests), endoscopic gastrin test, and intragastric pH measurements \[[@b2-kjim-2016-166]\]. Recently, the serum PG assay has become preferred to the serum gastrin assay in measuring the status of the gastric mucosa, because gastrin is produced primarily by the endocrine G cells of the antrum \[[@b3-kjim-2016-166],[@b4-kjim-2016-166]\]. A negative PG assay is indicative of healthy gastric mucosa with a negative predictive value of \> 99% using serum PG I/II \[[@b5-kjim-2016-166]\].

UGI endoscopy is performed biannually in Korea as a national screening system for secondary prevention of gastric cancer in all adults over 40 years of age. Nevertheless, there is no standardized reporting format used to describe the findings of background gastric mucosa, and endoscopic gastritis is often underestimated during the screening process. This review article focuses on the endoscopic findings of the background gastric mucosa in conjunction with intragastric conditions as reflected by serum PG assay findings.

INTACT STOMACH WITHOUT INFECTION
================================

The ability to secrete gastric acid and other gastric hormones is intact in subjects without *H. pylori* infection. The background gastric mucosa exhibits regular arrangements of the collecting venules when a subject has never been infected with *H. pylori* ([Fig. 2](#f2-kjim-2016-166){ref-type="fig"}). In hyperacidic conditions, multiple hyperemic erosions or linear streaks can occur on the antrum, which may lead to erosive gastritis (EG) or chronic superficial gastritis (CSG).

Chronic superficial gastritis
-----------------------------

CSG is characterized by multiple linear streaks on the greater curvature side of the antrum. CSG is the most common endoscopic gastritis in Korea, followed by EG, chronic atrophic gastritis (CAG), and metaplastic gastritis (MG) \[[@b6-kjim-2016-166]\]. Hyperemic streaks found in CSG do not require subsequent biopsy, since they are not associated with an increase in the risk of gastric cancer. CSG involves hyperacidic conditions. The secreting ability of the gastric mucosal cells remains intact.

Erosive gastritis
-----------------

EG presents with multiple raised erosions with hyperemic changes on the antrum. Erosions can be found in both noninfected subjects and in subjects with active *H. pylori* infection ([Table 1](#t1-kjim-2016-166){ref-type="table"}). In the absence of *H. pylori* infection, the incidence of gastric cancer is low \[[@b7-kjim-2016-166]\]. In EG, the intragastric conditions are hyperacidic, and the secreting ability of the gastric mucosal cells remains intact.

Other gastritis unrelated to *H. pylori* infection
--------------------------------------------------

Endoscopic gastritis in noninfected individuals is rare areas with endemic *H. pylori* infections. Type A autoimmune gastritis is an initially asymptomatic disease that progresses to corpus atrophy with pernicious adenoma (B12 deficiency) or iron deficiency anemia \[[@b8-kjim-2016-166]\]. Granulomatous gastritis is related to Crohn's disease, tuberculosis, syphilis, sarcoidosis, anisakiasis, or reaction to a foreign body. Eosinophilic gastroenteritis presents with non-specific gastrointestinal symptoms, and may involve the esophagus or colon \[[@b9-kjim-2016-166]\]. Others types of gastritis include collagenous gastritis, postradiation gastritis, and drug-related gastritis.

STOMACH WITH ACTIVE *H. PYLORI* INFECTION
=========================================

Active or acute *H. pylori* infection can be diagnosed by a gastric mucosal biopsy. The pathology findings show infiltrations of mononuclear cells and polymorphonuclear neutrophils. Because of the lack of a single endoscopic finding that indicates *H. pylori* infection, serology assays are often used to verify the status of the gastric mucosa.

Hemorrhagic spots, nodularity, and thickened gastric folds
----------------------------------------------------------

Typical endoscopic findings of acute *H. pylori* infection include hemorrhagic spots on the fundus and/or high-body, nodular gastritis, and hypertrophic gastric rugae ([Fig. 3](#f3-kjim-2016-166){ref-type="fig"}). The endoscopic findings of nodular gastritis are small, round, yellowish-white nodules that represent histological lymphoid follicles \[[@b10-kjim-2016-166]\]. Endoscopic nodular gastritis is more common at the antrum than the corpus in *H. pylori* infection.

Increased secreting ability of the gastric mucosal cells
--------------------------------------------------------

The secreting ability of the gastric mucosal cells is still intact during active *H. pylori* infection. Therefore, increased PG or acid secretion may occur upon stimulation or inflammation. Intragastric pH levels correlate well with *H. pylori* density and severity of gastritis \[[@b11-kjim-2016-166]\]. *H. pylori*-induced gastritis can be identified using serum PG levels, because PG II levels are increased and the PG I/II ratio is decreased in patients with *H. pylori* infection as compared with those without infection \[[@b12-kjim-2016-166],[@b13-kjim-2016-166]\]. Serum PG II concentration is known to be more useful in predicting active *H. pylori* infection than is PG I concentration.

Increased risk of diffuse-type gastric cancer
---------------------------------------------

Regardless of age, nodular gastritis increases the risk of gastric cancer \[[@b14-kjim-2016-166]\]. Although the serum PG assay is known to be more useful for the screening of intestinal-type gastric cancer than diffuse-type gastric cancer, a high PG II level indicates an increased risk of diffuse-type gastric cancer \[[@b15-kjim-2016-166]-[@b17-kjim-2016-166]\]. Therefore, *H. pylori* eradication is highly recommended in this stage of active infection; cellular changes seem to be reversible before the gastric mucosal cells progress beyond the point of no return \[[@b18-kjim-2016-166],[@b19-kjim-2016-166]\].

STOMACH WITH CHRONIC INACTIVE *H. PYLORI* INFECTION
===================================================

Chronic infection indicates an inactive *H. pylori* infection that produces atrophic changes with or without intestinal metaplasia (IM). MG is noticeable when the loss of glands in CAG evolves into IM, and open-type CAG is highly correlated with Cdx2 expression and MG \[[@b20-kjim-2016-166]\]. Nonetheless, there are limitations to pathologic evaluation using gastric biopsy in cases of MG, because it is hard to define an optimal biopsy site that would allow for evaluation of the entire stomach \[[@b21-kjim-2016-166],[@b22-kjim-2016-166]\].

Decreased secreting ability of the gastric mucosal cells
--------------------------------------------------------

Decreased serum PG I levels, open-type CAG, and old age are predictors of a hypoacidic state during *H. pylori* infection \[[@b23-kjim-2016-166]\]. Once the normal gastric glands are replaced by irreversible fibrosis and IM, the gastric environment becomes hypoacidic. For this reason, gastroesophageal reflux (GERD) is rare in subjects with CAG and/or MG \[[@b24-kjim-2016-166]\]. Advanced endoscopic grading of atrophic gastritis is inversely associated with GERD.

Gastric corpus atrophy as reflected by serum PG assay
-----------------------------------------------------

Gastric corpus atrophy is defined as a serum PG I/II ratio of \< 3.0 and a serum PG I level of \< 70 ng/mL \[[@b17-kjim-2016-166]\]. Although endoscopic, histological, and serological atrophic gastritis are well correlated, the presence of gastric corpus atrophy is not always consistent with CAG found by endoscopy \[[@b25-kjim-2016-166],[@b26-kjim-2016-166]\]. When histological atrophic gastritis progresses, serum PG I levels and the PG I/II ratio are decreased. Similarly, when the extent of atrophy is increased, the serum PG I/II ratio decreases. Moreover, the serum PG I/II ratio is significantly decreased in subjects with severe or moderate CAG than in those with mild CAG \[[@b27-kjim-2016-166]\].

Endoscopic findings of CAG and MG
---------------------------------

Endoscopic changes due to gastric atrophy are consequences of long-term *H. pylori* infection which progress from lesser curvature side of the antrum to greater curvature side of the corpus. Endoscopic findings of CAG reveal the extent of gastric atrophy by showing an atrophic border consisting of visible transparent vessels ([Fig. 4](#f4-kjim-2016-166){ref-type="fig"}). Endoscopy is a reliable method with high reproducibility which was shown to predict histological atrophy in a multinational study \[[@b28-kjim-2016-166]\]. Gastritis staging, so-called operative link on gastritis assessment (OLGA) staging, provides information on the gastric mucosa by integrating the atrophy score and topography \[[@b29-kjim-2016-166]\]. More recently, the Kyoto Global Consensus Meeting developed a global consensus on the classification of chronic gastritis \[[@b30-kjim-2016-166]\]. It is important to discriminate endoscopic findings based on their characteristics ([Fig. 5](#f5-kjim-2016-166){ref-type="fig"}).

In countries where *H. pylori* infection-related chronic gastritis is common, endoscopic findings or the serum PG assay are often combined to evaluate CAG and MG \[[@b31-kjim-2016-166],[@b32-kjim-2016-166]\]. MG exhibits various endoscopic findings such as irregular whitish mucosa, a villous appearance, mucosa with an uneven-surface, and patchy redness. Notably, CAG and/or MG induce spontaneous regression of *H. pylori*, because it is difficult for the bacterium to survive in the hypoacidic environment produced by severe CAG and/or MG \[[@b33-kjim-2016-166]-[@b36-kjim-2016-166]\]. Greater curvature side of the upper corpus seems to be the least atrophic and metaplastic site, and is the location in which *H. pylori* can survive for the longest period of time before spontaneous regression.

Increased risk of intestinal-type gastric cancer and dysplasia
--------------------------------------------------------------

Endoscopic and serologic findings of CAG and MG are good tools for predicting the risk of gastric carcinogenesis \[[@b37-kjim-2016-166]\]. Subjects with a low PG I/II ratio are at an increased risk for intestinal-type gastric cancer and dysplasia \[[@b38-kjim-2016-166]\]. One study showed the significance of the topography of histologic gastritis as a marker to identify individuals at high risk for gastric cancer; pangastritis put patients at the highest risk, followed by corpus-predominant gastritis and antrum-predominant gastritis \[[@b39-kjim-2016-166]\]. Furthermore, MG is also a predictive marker for intestinal-type gastric cancer \[[@b40-kjim-2016-166]\]. A study showed that IM on greater curvature side of the corpus, along with a decreased serum PG I level, indicates a high risk of intestinal-type gastric cancer and dysplasia \[[@b41-kjim-2016-166]\].

STOMACH WITH PAST *H. PYLORI* INFECTION
=======================================

The ability of gastric mucosa cells to heal from an *H. pylori* infection depends on the period of bacterial regression. If *H. pylori* is eradicated before the point of no return, gastric mucosa regains its secreting ability, and serum PG concentrations start to increase ([Fig. 6](#f6-kjim-2016-166){ref-type="fig"}). This is rare in cases of spontaneous regression of *H. pylori* infection, in which most damage to the gastric mucosa is irreversible.

Infections eradicated at a reversible stage
-------------------------------------------

A long-term follow-up study showed that the changes induced by mild CAG and CSG are reversible, in both histological and serological findings \[[@b42-kjim-2016-166]\]. The degrees of inflammation and activity, and lymphoid follicle infiltration decrease after *H. pylori* eradication \[[@b43-kjim-2016-166]\]. Serum PG II is a good marker of intragastric environmental changes before and after *H. pylori* eradication \[[@b44-kjim-2016-166]\].

Notably, even severe gastric atrophy and IM are reversible in some patients \[[@b45-kjim-2016-166]\]. It has been reported that some cases of MG and corpus-predominant gastritis with a low serum PG I/II ratio were reversible \[[@b46-kjim-2016-166],[@b47-kjim-2016-166]\]. On the contrary, no significant changes were found in the molecular alterations related to carcinogenesis even after *H. pylori* eradication \[[@b48-kjim-2016-166]\].

Infections eradicated at an irreversible stage
----------------------------------------------

The cancer risk after eradication depends on the extent of CAG before eradication, and is highly correlated with the severity of corpus atrophy \[[@b49-kjim-2016-166],[@b50-kjim-2016-166]\]. In subjects with irreversible damage to the gastric mucosa, serum PG I levels and PG I/II ratio continue to decrease. Therefore, periodic endoscopic screening is required \[[@b51-kjim-2016-166]\]. Nevertheless, only 5% of patients with severe CAG develop intestinal-type gastric cancer \[[@b52-kjim-2016-166]\]. There is no consensus in Korea on the role of eradication in the prevention of gastric cancer \[[@b53-kjim-2016-166]-[@b55-kjim-2016-166]\], but endoscopic screening is recommended for these subjects, as it is for Korean Americans with known CAG, IM, or a family history of gastric cancer \[[@b56-kjim-2016-166]\].

Spontaneous regression of *H. pylori*
-------------------------------------

Spontaneous regression occurs in the most severe, late stages of gastric atrophy and/or IM when the stomach environment is inhospitable for *H. pylori* growth \[[@b57-kjim-2016-166]\]. In such advanced conditions, the serum anti-*H. pylori* immunoglobulin G (IgG) assay reverts to a negative finding \[[@b58-kjim-2016-166]\]. This indicates hypoacidity of the stomach, and also provides a rationale for measuring serum PG levels as a secondary means of gastric cancer screening \[[@b59-kjim-2016-166]\]. Subjects with gastric corpus atrophy and low *H. pylori* concentration show the most impaired acid secretion and the highest risk of intestinal-type gastric cancer. Taken together, the greatest risk for intestinal-type gastric cancer is found in seronegative subjects with past infections and low PG I/II ratios \[[@b60-kjim-2016-166]-[@b62-kjim-2016-166]\].

CONCLUSIONS
===========

Endoscopic gastritis reflects the excretion ability of the gastric mucosa and indicates whether the intragastric conditions are hypoacidic or hyperacidic. Nodularity, multiple hemorrhagic spots, and thickened gastric folds indicate active *H. pylori* infection, while atrophy and metaplasia indicate chronic inactive *H. pylori* infection. Antacids are helpful in the treatment of subjects with hyperacidic stomachs and increased serum PG levels, but not in those with hypoacidic stomachs and decreased PG levels. The risk of diffuse-type gastric cancer is highest in subjects with active infections, increased serum PG II concentrations, and endoscopic findings indicating nodular gastritis, hemorrhagic spots, and hypertrophic gastric rugae. On the contrary, the risk of intestinal-type gastric cancer is highest in subjects with chronic inactive infections, decreased serum PG I concentrations, and endoscopic findings of CAG and MG. By understanding serum PG assay findings and typical endoscopic gastritis findings of infected and noninfected stomachs, physicians will be able to identify the subjects who would benefit from taking acid suppressants with or without *H. pylori* eradication. Prevention of gastric cancer will be maximized when both serologic and endoscopic findings can be utilized as secondary measures, along with *H. pylori* eradication as a primary prevention.
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![Endoscopic findings of the background gastric mucosa according to the gastric carcinogenesis pathway. Upon *Helicobacter pylori* infection, the gastric mucosa shows changes indicating active infection, such as multiple hemorrhagic spots, nodules, and thickening of the gastric rugae. During this stage, the risk of diffuse-type gastric cancer is increased, the intragastric environment becomes hyperacidic, and there is an increase in serum pepsinogen (PG) levels. When active inflammation subsides and the infection progress to a chronic stage, the background gastric mucosa shows atrophy and metaplasia. This long-term, slow process increases the risk of intestinal-type gastric cancer, the intragastric environment becomes hypoacidic, and there is a decrease in serum PG levels.](kjim-2016-166f1){#f1-kjim-2016-166}

![(A) Endoscopic findings in subjects without *Helicobacter pylori* infection. Pepsinogen (PG) I is produced exclusively by chief cells and mucus neck cells on the fundus. PG II is secreted throughout the stomach and also from the Brunner's gland of the duodenal bulb. (B) Normal endoscopic finding of the angle in noninfected subject. The regular arrangement of the collecting venules on the angle indicate normal gastric mucosa. (C) Normal finding of the corpus in the same subject. The regular arrangement of the collecting venules extends up to the on the cardia and fundus. (D) Chronic superficial gastritis. Several hyperemic streaks are noticed on greater curvature side of the antrum. (E) Erosive gastritis. Multiple raised, hyperemic erosions are visible on the antrum.](kjim-2016-166f2){#f2-kjim-2016-166}

![(A) Endoscopic findings in subjects with active *Helicobacter pylori* infection. (B) Nodular gastritis on the anterior-greater side of the proximal antrum. Multiple small nodules are visible on the antrum, extending up to greater curvature side of the corpus. The nodules consist of submucosal elevated lesions, and thus, there is no color change in nodular gastritis. (C) Follow-up findings of enlarged nodules on the proximal antrum to low-body in the same patient. The previously noted tiny, regular nodules have increased in size. The nodules were irregular and had grown from 12 months prior. (D) Finding of hemorrhagic spots on the fundus in nodular gastritis patient at initial endoscopy (B). Multiple tiny reddish spots, so-called diffuse redness, can be seen on the fundus and greater curvature side of the corpus. (E) Hypertrophic gastric folds. Thickened gastric rugae with whitish, sticky exudates indicate active *H. pylori* infection. PG, pepsinogen.](kjim-2016-166f3){#f3-kjim-2016-166}

![(A) Endoscopic findings in subjects with chronic *Helicobacter pylori* infection. Therefore, the serum pepsinogen (PG) I level is decreased only when the fundus is damaged by atrophic changes. Based on these findings, gastric corpus atrophy is defined as a serum PG I/II ratio of \< 3.0 and a PG I level of \< 70 ng/mL, and is widely used for gastric cancer screening for the detection of high risk individuals. (B) Closed-type atrophic gastritis. Visible transparent vessels can be seen on the anterior-lesser curvature side of the low-body to the angle. An atrophic border is present. (C) Open-type atrophic gastritis. Visible transparent vessels are extended up to the cardia without an atrophic border. (D) Metaplastic gastritis. Multiple large, irregular whitish elevations are present on the distal part of the antrum. This is a common endoscopic finding in subjects with atrophic gastritis on the corpus. (E) Diffuse, irregular whitish changes in metaplastic gastritis. Intestinal metaplasia can have a variety of appearances, such as whitish, nodular elevations. Geographic and hyperemic changes can be also found in metaplastic gastritis.](kjim-2016-166f4){#f4-kjim-2016-166}

![Different endoscopic findings of nodular gastritis, metaplastic gastritis, and erosive gastritis. (A) Nodular gastritis. On the distal part of the antrum, multiple elevated nodules are seen without color change. The nodules are regular in size and shape. (B) Metaplastic gastritis. Intestinal metaplasia can be confused when hyperemic mucosa is augmented by whitish surrounding mucosa. The elevations are irregular in size, shape, and color. (C) Erosive gastritis. Elevated hyperemic erosions are scattered on the antrum.](kjim-2016-166f5){#f5-kjim-2016-166}

![Different prognoses in two *Helicobacter pylori*-infected subjects. (A) Endoscopic findings of a 55-year-old man. A single, raised erosion is present on the greater curvature side of the pylorus. A serum anti-*H. pylori* immunoglobulin G (IgG) assay was positive on the day of endoscopic examination. The serum pepsinogen (PG) I level was 25.8 ng/mL, the PG II level was 12.2 ng/mL, and the PG I/II ratio was 2.1 (normal values: PG I \> 70.0 ng/mL, PG II \< 15.0 ng/mL, PG I/II ratio \> 3.0). Pathology test results revealed chronic gastritis with marked intestinal metaplasia, and Giemsa staining was negative. (B) Forty-three months after the initial tests. The patient revisited our clinic for follow-up testing. The serum anti-*H. pylori* IgG assay was still positive, and the serum PG I level and PG I/II ratio had decreased (PG I 24.0 ng/mL, PG II 13.0 ng/mL, PG I/II ratio 1.8). Pathology test results and Giemsa staining were not altered. (C) Endoscopic findings of a 62-year-old man. The serum anti-*H. pylori* IgG assay was positive, and the serum PG assay finding was also positive (PG I 28.6 ng/mL, PG II 14.5 ng/mL, PG I/II ratio 2.0). Active gastritis with foveolar hyperplasia and regenerated glands were found on the biopsy, and Giemsa staining was positive. (D) Follow-up endoscopy 1 year after successful *H. pylori* eradication. The serum anti-*H. pylori* IgG test became negative, and the serum PG I/II ratio had increased (PG I 29.0 ng/mL, PG II 10.4 ng/mL, PG I/II ratio 2.7). Pathology test results revealed chronic gastritis without *H. pylori*-like microorganisms, and Giemsa staining was negative.](kjim-2016-166f6){#f6-kjim-2016-166}

###### 

Common endoscopic findings in an endemic area of *Helicobacter pylori* infection

  Status of *H. pylori* infection   Endoscopic diagnosis                                                           Gross findings                                                               Location of the lesion                                                Secreting ability   Intragastric acidity          Serum PG assay findings
  --------------------------------- ------------------------------------------------------------------------------ ---------------------------------------------------------------------------- --------------------------------------------------------------------- ------------------- ----------------------------- -----------------------------
  No infection                      Chronic superficial gastritis                                                  Several hyperemic streaks                                                    Antrum, greater curvature side                                        Intact              Normoacidic                   Normal
  No correlation with infection     Erosive gastritis                                                              Several hyperemic, raised lesions                                            Antrum                                                                Intact              Hyperacidic                   Normal
  Active infection                  Nodular gastritis                                                              Multiple tiny and regular submucosal elevated lesions without color change   Antrum extending toward corpus                                        Intact              Hyperacidic                   Increased serum PG II level
  Hemorrhagic spots                 Multiple tiny and regular reddish spots                                        Corpus (fundus and high-body)                                                Intact                                                                Hyperacidic         Increased serum PG II level   
  Hypertrophic gastric rugae        Several thickened rugae with edematous change and whitish, sticky secretions   Corpus                                                                       Intact                                                                Hyperacidic         Increased serum PG II level   
  Chronic inactive infection        Chronic atrophic gastritis                                                     Visible transparent vessels                                                  Antrum, lesser curvature side toward corpus, greater curvature side   Impaired            Hypoacidic                    Decreased serum PG I level
  Metaplastic gastritis             Multiple large and irregular whitish elevations                                Antrum extending toward corpus                                               Impaired                                                              Hypoacidic          Decreased serum PG I level    

PG, pepsinogen.
